Header cover image

Belgian (BEL20) Pharma Industry Analysis

UpdatedApr 16, 2024
DataAggregated Company Financials
Companies3
  • 7D3.5%
  • 3M39.7%
  • 1Y31.7%
  • YTDn/a

All of the companies in the Pharma industry have been up over the last week, with the industry up 4.9%. This takes the industry's 12 month performance to a gain of 33%. Looking forward, earnings are forecast to grow by 27% annually.

Industry Valuation and Performance

Has the Belgian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 16 Apr 2024€27.1b€5.2b€415.4m56.4x65.3x5.2x
Thu, 14 Mar 2024€24.5b€5.2b€415.7m51.8x58.9x4.7x
Sat, 10 Feb 2024€21.7b€5.1b€404.7m47.6x53.6x4.2x
Mon, 08 Jan 2024€19.2b€5.1b€404.7m42.7x47.4x3.8x
Wed, 06 Dec 2023€17.3b€5.1b€404.7m39x42.7x3.4x
Fri, 03 Nov 2023€16.3b€5.1b€408.5m35.7x39.8x3.2x
Sun, 01 Oct 2023€18.1b€5.1b€408.5m39.2x44.2x3.5x
Tue, 29 Aug 2023€19.2b€5.2b€350.6m41x54.7x3.7x
Thu, 27 Jul 2023€18.9b€5.5b€434.8m36.9x43.5x3.4x
Sat, 24 Jun 2023€19.5b€5.5b€434.8m37.9x45x3.5x
Mon, 22 May 2023€20.7b€5.5b€434.8m40.3x47.5x3.7x
Wed, 19 Apr 2023€20.4b€5.5b€669.3m25x30.6x3.7x
Fri, 17 Mar 2023€18.9b€5.5b€669.3m23.1x28.2x3.4x
Sun, 12 Feb 2023€18.9b€5.9b€1.1b13.7x17.2x3.2x
Tue, 10 Jan 2023€18.8b€5.9b€1.1b13.7x17.1x3.2x
Thu, 08 Dec 2022€17.5b€5.9b€1.1b12.6x15.9x3x
Sat, 05 Nov 2022€18.2b€5.9b€1.1b12.9x16.5x3.1x
Mon, 03 Oct 2022€17.3b€5.9b€1.1b12.4x15.7x2.9x
Wed, 31 Aug 2022€17.4b€5.9b€1.1b12.5x16.1x3x
Fri, 29 Jul 2022€19.5b€5.8b€1.3b11.7x14.9x3.4x
Sun, 26 Jun 2022€19.7b€5.8b€1.2b11.8x15.8x3.4x
Tue, 24 May 2022€20.0b€5.8b€1.2b12x16.1x3.4x
Thu, 21 Apr 2022€26.4b€5.8b€1.3b15.7x20.9x4.5x
Sat, 19 Mar 2022€25.1b€5.8b€1.3b14.7x19.8x4.3x
Mon, 14 Feb 2022€21.4b€5.5b€1.1b14.2x19.3x3.9x
Wed, 12 Jan 2022€23.2b€5.5b€1.1b15.3x20.9x4.2x
Fri, 10 Dec 2021€24.1b€5.5b€1.1b15.7x21.8x4.4x
Sun, 07 Nov 2021€25.4b€5.5b€1.1b16.9x22.9x4.6x
Tue, 05 Oct 2021€23.8b€5.5b€1.1b15.8x21.5x4.3x
Thu, 02 Sep 2021€20.2b€5.5b€804.9m19.9x25x3.6x
Sat, 31 Jul 2021€18.7b€5.5b€804.9m18.4x23.2x3.4x
Tue, 04 May 2021€16.2b€5.4b€704.9m17.5x22.9x3x
Price to Earnings Ratio

22.9x


Total Market Cap: €16.2bTotal Earnings: €704.9mTotal Revenue: €5.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Belgian Pharma Industry Price to Earnings3Y Average 29.4x202220232024
Current Industry PE
    There are only 3 companies in the Belgian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 16% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Belgian Pharma compare with similar industries?

BE Market-1.53%
Healthcare1.85%
Pharma3.50%
Pharma3.50%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
UCB UCB€119.454.4%
+€948.8m
36.0%PE66.1x
MITRA Mithra Pharmaceuticals€0.232.2%
+€345.5k
-92.4%PS0.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.